Cambiar Investors LLC Sells 6,925 Shares of HealthStream, Inc. (NASDAQ:HSTM)

Cambiar Investors LLC lowered its position in HealthStream, Inc. (NASDAQ:HSTMFree Report) by 7.9% in the fourth quarter, Holdings Channel.com reports. The fund owned 80,530 shares of the technology company’s stock after selling 6,925 shares during the period. Cambiar Investors LLC’s holdings in HealthStream were worth $2,561,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other hedge funds also recently modified their holdings of the company. GAMMA Investing LLC lifted its position in shares of HealthStream by 36.0% in the 3rd quarter. GAMMA Investing LLC now owns 1,355 shares of the technology company’s stock worth $39,000 after acquiring an additional 359 shares during the period. The Manufacturers Life Insurance Company lifted its position in shares of HealthStream by 10.0% in the 2nd quarter. The Manufacturers Life Insurance Company now owns 9,671 shares of the technology company’s stock worth $270,000 after acquiring an additional 876 shares during the period. Quarry LP bought a new stake in shares of HealthStream in the 3rd quarter worth approximately $27,000. Ellsworth Advisors LLC lifted its position in shares of HealthStream by 5.1% in the 3rd quarter. Ellsworth Advisors LLC now owns 20,035 shares of the technology company’s stock worth $578,000 after acquiring an additional 972 shares during the period. Finally, Diversified Trust Co lifted its position in shares of HealthStream by 20.5% in the 4th quarter. Diversified Trust Co now owns 8,733 shares of the technology company’s stock worth $278,000 after acquiring an additional 1,486 shares during the period. Institutional investors own 69.58% of the company’s stock.

Wall Street Analyst Weigh In

A number of brokerages have commented on HSTM. Craig Hallum upgraded HealthStream to a “strong-buy” rating in a research report on Thursday, October 17th. Canaccord Genuity Group raised their price objective on HealthStream from $28.00 to $29.00 and gave the stock a “hold” rating in a research report on Wednesday, October 23rd. JMP Securities reissued a “market perform” rating on shares of HealthStream in a report on Thursday, February 6th. Finally, Barclays increased their target price on HealthStream from $32.00 to $34.00 and gave the stock an “overweight” rating in a report on Wednesday, October 23rd. Two analysts have rated the stock with a hold rating, three have assigned a buy rating and one has issued a strong buy rating to the company. Based on data from MarketBeat.com, the company has a consensus rating of “Moderate Buy” and an average price target of $31.50.

Check Out Our Latest Stock Analysis on HSTM

HealthStream Trading Up 1.0 %

Shares of HSTM opened at $33.50 on Tuesday. The stock has a 50 day simple moving average of $32.20 and a 200-day simple moving average of $30.41. HealthStream, Inc. has a 1 year low of $23.92 and a 1 year high of $33.78. The stock has a market cap of $1.02 billion, a PE ratio of 51.54, a PEG ratio of 4.30 and a beta of 0.39.

HealthStream Company Profile

(Free Report)

HealthStream, Inc provides Software-as-a-Service (SaaS) based applications for healthcare organizations in the United States. The company’s solutions help healthcare organizations in meeting their ongoing clinical development, talent management, training, education, assessment, competency management, safety and compliance, and scheduling, as well as provider credentialing, privileging, and enrollment needs.

Read More

Want to see what other hedge funds are holding HSTM? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for HealthStream, Inc. (NASDAQ:HSTMFree Report).

Institutional Ownership by Quarter for HealthStream (NASDAQ:HSTM)

Receive News & Ratings for HealthStream Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HealthStream and related companies with MarketBeat.com's FREE daily email newsletter.